JP6160011B2 - ＩｇＡ分泌促進剤 - Google Patents

ＩｇＡ分泌促進剤 Download PDF

Info

Publication number
JP6160011B2
JP6160011B2 JP2013021411A JP2013021411A JP6160011B2 JP 6160011 B2 JP6160011 B2 JP 6160011B2 JP 2013021411 A JP2013021411 A JP 2013021411A JP 2013021411 A JP2013021411 A JP 2013021411A JP 6160011 B2 JP6160011 B2 JP 6160011B2
Authority
JP
Japan
Prior art keywords
iga
iga secretion
dextrin
secretion promoter
indigestible dextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013021411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014152125A5 (enExample
JP2014152125A (ja
Inventor
祥子 宮里
祥子 宮里
由香 岸本
由香 岸本
朗 細野
朗 細野
恭子 高橋
恭子 高橋
修一 上野川
修一 上野川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Matsutani Chemical Industries Co Ltd
Original Assignee
Matsutani Chemical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsutani Chemical Industries Co Ltd filed Critical Matsutani Chemical Industries Co Ltd
Priority to JP2013021411A priority Critical patent/JP6160011B2/ja
Priority to KR1020130040848A priority patent/KR20140100380A/ko
Priority to TW102113294A priority patent/TWI598102B/zh
Priority to US13/871,517 priority patent/US20140220080A1/en
Publication of JP2014152125A publication Critical patent/JP2014152125A/ja
Publication of JP2014152125A5 publication Critical patent/JP2014152125A5/ja
Application granted granted Critical
Publication of JP6160011B2 publication Critical patent/JP6160011B2/ja
Priority to KR1020190048192A priority patent/KR101985644B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
    • C08B30/18—Dextrin, e.g. yellow canari, white dextrin, amylodextrin or maltodextrin; Methods of depolymerisation, e.g. by irradiation or mechanically
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2013021411A 2013-02-06 2013-02-06 ＩｇＡ分泌促進剤 Active JP6160011B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2013021411A JP6160011B2 (ja) 2013-02-06 2013-02-06 ＩｇＡ分泌促進剤
KR1020130040848A KR20140100380A (ko) 2013-02-06 2013-04-15 IgA 분비 촉진제
TW102113294A TWI598102B (zh) 2013-02-06 2013-04-15 使用難消化性糊精在製備IgA分泌促進劑、黏膜免疫活化劑、抗感染症劑及抗過敏劑的用途
US13/871,517 US20140220080A1 (en) 2013-02-06 2013-04-26 IgA SECRETION PROMOTER
KR1020190048192A KR101985644B1 (ko) 2013-02-06 2019-04-25 면역 증진제 및 이를 포함하는 면역 개선용 음식품 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013021411A JP6160011B2 (ja) 2013-02-06 2013-02-06 ＩｇＡ分泌促進剤

Publications (3)

Publication Number Publication Date
JP2014152125A JP2014152125A (ja) 2014-08-25
JP2014152125A5 JP2014152125A5 (enExample) 2016-04-07
JP6160011B2 true JP6160011B2 (ja) 2017-07-12

Family

ID=51259397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013021411A Active JP6160011B2 (ja) 2013-02-06 2013-02-06 ＩｇＡ分泌促進剤

Country Status (4)

Country Link
US (1) US20140220080A1 (enExample)
JP (1) JP6160011B2 (enExample)
KR (2) KR20140100380A (enExample)
TW (1) TWI598102B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7359374B2 (ja) 2017-10-26 2023-10-11 株式会社ダイセル 腸管免疫亢進剤、食品、及び医薬

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04179459A (ja) * 1990-11-13 1992-06-26 Matsutani Kagaku Kogyo Kk 大腸癌予防作用を有する食品用又は飼料用組成物
JPH05178902A (ja) * 1991-10-29 1993-07-20 Matsutani Kagaku Kogyo Kk 難消化デキストリン
JP2003201239A (ja) 2001-11-05 2003-07-18 Meiji Milk Prod Co Ltd 免疫賦活食品組成物
KR100485154B1 (ko) * 2002-05-22 2005-04-22 주식회사 삼양제넥스 난소화성 덱스트린을 포함하는 면역활성 조성물
JP2005047829A (ja) * 2003-07-30 2005-02-24 Taiyo Kagaku Co Ltd 炎症性腸疾患の予防・治療剤
RU2388478C2 (ru) * 2003-10-24 2010-05-10 Н.В. Нютрисиа Иммуномодулирующие олигосахариды
JP4382465B2 (ja) 2003-12-16 2009-12-16 三井農林株式会社 粘膜免疫賦活剤
JP2005289847A (ja) * 2004-03-31 2005-10-20 Unitika Ltd 血糖値上昇抑制剤
EP1629727A1 (en) * 2004-08-24 2006-03-01 N.V. Nutricia Composition containing fermentable polysaccharides
ES2369789T3 (es) * 2005-04-21 2011-12-07 The Hokuren Federation Of Agricultural Cooperatives 1-kestosa para tratar alergias y dermatitis atópica.
JP5367228B2 (ja) * 2007-02-28 2013-12-11 公立大学法人大阪府立大学 腸管免疫賦活化剤及び抗アレルギー剤
JP2010254594A (ja) * 2009-04-22 2010-11-11 Fujifilm Corp 腸内バクテロイデス増殖促進剤
JP2011184300A (ja) * 2010-03-04 2011-09-22 Lotte Co Ltd イムノグロブリンａ分泌促進剤

Also Published As

Publication number Publication date
TW201431555A (zh) 2014-08-16
KR20140100380A (ko) 2014-08-14
US20140220080A1 (en) 2014-08-07
KR101985644B1 (ko) 2019-06-03
TWI598102B (zh) 2017-09-11
JP2014152125A (ja) 2014-08-25
KR20190046728A (ko) 2019-05-07

Similar Documents

Publication Publication Date Title
Tester et al. Glucomannans and nutrition
EP1465505B1 (en) Stimulation of the immune system with polydextrose
JP4456329B2 (ja) 炎症過程及び非特異的免疫パラメータの異常活性化を減少させるためのプレバイオティクスを含む組成物
RU2376889C2 (ru) Пищевой продукт и напиток, модулирующий кишечную флору человека, пищевые добавки, способы их получения и применения препаратов арабиноксилана
JP2010254702A (ja) 粘稠性繊維と粘度低下性タンパク質とを含む組成物
CN106714582B (zh) 慢消化性持续型能量补充剂
JP2006512298A (ja) 水素化形態の縮合パラチノース
WO2004089992A1 (ja) 改質アラビアガムおよびその用途
US20210330729A1 (en) Dietary fiber compositions
US20130302471A1 (en) Composition of purified soluble mannans for dietary supplements and methods of use thereof
JP6160011B2 (ja) ＩｇＡ分泌促進剤
Dong et al. The gastrointestinal metabolic effects of oat product based-β-glucan in mice
JP6742981B2 (ja) 免疫調節剤及びその用途
JP2023062564A (ja) 組成物
US20160324904A1 (en) Supplement for improving immunotolerance, intestinal environment and intestinal tract barrier
Atta et al. A Comprehensive Review on Health Benefits of Fructooligosaccharides
Sharma et al. Prebiotics: A review of therapeutic potential
JP2013181003A (ja) ＩｇＡ産生促進剤
CN114304651A (zh) 提高免疫力组合物
JP2008280466A (ja) 非消化性アミロース粒子、その製造方法、ならびにそれを含有する飲食品、医薬品および医薬部外品
Anadón et al. Prebiotics: safety and toxicity considerations
US20180071237A1 (en) Treatment method for improving intestinal enviornment and intestinal tract barrier
EP4249052A1 (en) Composition for improving intestinal bacterial flora and composition for suppressing production of substances by intestinal putrefaction
Lestari et al. Effect of Fiber Drink Consumption Containing Glucomannan and Isomaltooligosaccharide on Digesta Profile and Gut Microbiota
JP2017132708A (ja) 食物繊維組成物およびその製造方法

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20140611

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140611

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151224

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161017

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161216

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170522

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170526

R150 Certificate of patent or registration of utility model

Ref document number: 6160011

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250